# Top 50 Biotechnology Startup Investors in Sweden in June 2026

## Sciety
- Type: VC Fund
- Location: Stockholm, Stockholms Lan, Sweden
- Relevant deals: 16
- Stages: Seed, Series A
- Focus: Health Care, Biotechnology, Medical

Whether you are an investor or entrepreneur, partner with Sciety to achieve impactful returns and elevate your life science business in the Nordics.

## Chalmers Ventures AB
- Type: VC Fund
- Location: Göteborg, Vastra Gotaland, Sweden
- Relevant deals: 15
- Stages: Pre-Seed, Seed
- Focus: Software, Biotechnology, Health Care

We are a leading tech investor & venture builder in the Nordics. Taking deep tech from lab to market.WELCOMEINVESTMENTS

## Industrifonden
- Type: VC Fund
- Location: Stockholm, Stockholms Lan, Sweden
- Relevant deals: 14
- Stages: Series A, Seed
- Focus: Software, Biotechnology, Information Technology

Industrifonden is a Nordic evergreen venture capital firm with a fund size of $600m, that focuses on early-stage technology and life science companies with international potential. The company works long term with the entrepreneurs we invest in, and have a strong track record of building game changing companies. Industrifonden-backed companiesinclude tech companies Qlik, Arcam, Soundtrack Your Brand, Fishbrain, and life science companies CellaVision, Oncopeptides and AMRA.

## Almi Invest
- Type: VC Fund
- Location: Stockholm, Stockholms Lan, Sweden
- Relevant deals: 13
- Stages: Seed, Pre-Seed
- Focus: Software, Health Care, Information Technology

Almi Invest is Sweden’s most active early-stage venture capital firm, investing in scalable startups across Sustainability, Industry, Tech, and Life Science.We invest from pre-seed to Series A, always co-investing with independent private investors to accelerate innovation and long-term success. Our portfolio spans sustainable solutions,industrial innovation, deep tech, SaaS, and life science, supporting startups that drive economic and environmental progress.With €430 million under management and over 1,000 investments since 2009, we have backed leading companies like MIPS, Tobii, and Neo4j, with notable exits to Google, Apple, Microsoft, and Qlik.Beyond capital, we offer engaged ownership, providing strategic guidance, active board participation, and access to an extensive investor network.Almi Invest is part of the Almi Group and is funded by the European Regional Development Fund, Almi AB, and regional partners.

## Navigare Ventures
- Type: VC Fund
- Location: Stockholm, Stockholms Lan, Sweden
- Relevant deals: 7
- Stages: Seed, Series B
- Focus: Biotechnology, Energy, Health Care

Welcome to Navigare Ventures. We invest in transformational early-stage companies at the frontier of science and technology.

## Novo Holdings
- Type: VC Fund
- Location: Hellerup, Hovedstaden, Denmark
- Relevant deals: 5
- Stages: Series A, Series B, Series C
- Focus: Biotechnology, Health Care, Medical

Novo Holdings is a world-leading life science investor with a focus on creating long-term value.

## HealthCap
- Type: VC Fund
- Location: Stockholm, Stockholms Lan, Sweden
- Relevant deals: 5
- Stages: Series B, Series A
- Focus: Biotechnology, Health Care, Medical

HealthCap, a life science investor and company creator. Our motivation is to find innovative ideas and invest that could impact healthcare and society.

## Norrsken VC
- Type: VC Fund
- Location: Stockholm, Stockholms Lan, Sweden
- Relevant deals: 4
- Stages: Seed, Series A
- Focus: Software, Health Care, Food and Beverage

We are a venture capital fund investigating in Start-Ups solving the worlds biggest problems while building massive businesses.

## Karolinska
- Type: VC Fund
- Location: Solna, Stockholms Lan, Sweden
- Relevant deals: 4
- Stages: Seed, Series A
- Focus: Biotechnology, Health Care, Pharmaceutical

Karolinska Development aims to create value for patients, researchers, investors and society by developing innovations from world class science into products that can be sold or out-licensed with high returns. The business model is to: SELECT the most commercially attractive medical innovations; DEVELOP innovations to the stage where the greatestreturn on investment can be achieved; and COMMERCIALIZE the innovations through the sale of companies or out-licensing of products.Karolinska Development has developed a well-structured selection process to identify the most commercially attractive medical innovations screened by KIAB. Pharmaceutical development is a high-risk enterprise. In most cases, development projects fail because of side effects or insufficient efficacy. Successful selection of innovations is fundamental to Karolinska Development’s business model, which makes the inflow of new projects crucial. One key to success lies in selecting those innovations that can be developed from scientific findings to products and have significant commercial potential. To date, over 1,300 projects have been screened by KIAB.The portfolio companies are often founded together with the innovators and are initially operated as virtual companies with few or no employees. During the first six to twelve months, the companies normally have minimal fixed costs and technological development is outsourced.The innovator, who is often employed at an academic institution, normally participates as a board member and scientific advisor. The CEO of a portfolio company cooperates closely with a representative of Karolinska Development, who in most cases is also a board member of the company. The companies are capitalized to reach their next milestone, usually within a period of six to eighteen months. Development projects are continuously monitored, and those that do not meet their stipulated targets are discontinued. In the first three to four years, a portfolio company’s operating expenses are often limited to a few million Swedish kronor per year, which cover the cost of external studies and the salary of the staff. In subsequent years, Karolinska Development and other investors play an important role recruiting key expertise to the companiesKarolinska Development intends to realize value by exiting portfolio companies or through out-licensing of projects. Such transactions (especially out-licensing) are often structured as single upfront payments followed by payments based on predetermined milestones and royalties on sales. Although Karolinska Development has a flexible exit strategy, pharmaceutical products are, for two reasons, preferably exited at Phase II. First a successful Phase II study indicates that the pharmaceutical has an effect on patients, which is an important value-enhancing factor when negotiating out-licensing or sales. Secondly, finalizing product development and undertaking Phase III clinical trials frequently requires very large patient populations. In many cases this requires much greater resources than those available at Karolinska Development but these can be found in established pharmaceutical companies. Several licensing deals were closed in 2011 involving projects with a similar focus and development phase to Karolinska Development's projects.

## Inventure
- Type: VC Fund
- Location: Helsinki, Southern Finland, Finland
- Relevant deals: 3
- Stages: Seed, Series A, Series B
- Focus: Software, Information Technology, Health Care

Since 2005, Inventure has backed over 90 companies including Wolt, Swappie, Jobbatical, aiMotive, and more.

## Crowberry Capital
- Type: VC Fund
- Location: Reykjavík, Gullbringusysla, Iceland
- Relevant deals: 3
- Stages: Seed, Series A, Pre-Seed
- Focus: Software, Gaming, Health Care

Crowberry Capital invests at seed and early stage in emerging technology ventures in the Nordics. Our mission is to back people that are good for companies and build companies that are good for people. We have a strong follow-through philosophy and commit to putting your company first.

## Partnerinvest Norr
- Type: VC Fund
- Location: Piteå, Norrbottens Lan, Sweden
- Relevant deals: 3
- Stages: Seed, Series A
- Focus: Software, Manufacturing, Information Technology

Partnerinvest Norr is a private equity firm specialized in software, security, and biometrics sectors.
Partnerinvest Övre Norrland AB is a venture capital firms that seeks to invest in limited companies which have are in the expansion phase.


## BackingMinds
- Type: VC Fund
- Location: Stockholm, Stockholms Lan, Sweden
- Relevant deals: 3
- Stages: Seed, Pre-Seed
- Focus: SaaS, Software, Agriculture

We help great minds unleash their full potential!

## Voima Ventures
- Type: VC Fund
- Location: Helsinki, Southern Finland, Finland
- Relevant deals: 3
- Stages: Seed, Pre-Seed, Series A
- Focus: Biotechnology, Health Care, Artificial Intelligence

Voima Ventures’ mission is to solve major global problems by combining science, entrepreneurship, and value adding capital. They shed light on the ideas and technology which require time and courage to build. Industry domains include bio and new materials, medical technologies and life sciences, imaging and optics, IoT and electronics, robotics,software & ICT and AI. In addition, Voima Ventures has invested in more than 30 deep tech startups, including companies like Solar Foods, Infinited Fiber Company, and Dispelix. Cornerstone investors are VTT Technical Research Centre of Finland and European Investment Fund (EIF), backed by Finnish private and institutional investors.

## Nina Capital
- Type: VC Fund
- Location: Barcelona, Catalonia, Spain
- Relevant deals: 2
- Stages: Seed, Pre-Seed, Series A
- Focus: Health Care, Artificial Intelligence, Software

We deploy early stage capital to fuel the growth of need-driven health technology companies.

## Noaber
- Type: VC Fund
- Location: Lunteren, Gelderland, The Netherlands
- Relevant deals: 2
- Stages: Seed, Series A
- Focus: Health Care, Medical, Fitness

Noaber Ventures invests in initiatives that bring social transformations using information technology.

## Nordic Science Investments
- Type: VC Fund
- Relevant deals: 2
- Stages: Seed, Pre-Seed, Series A
- Focus: Biotechnology, Medical, Health Diagnostics

We partner with founders to transform unseen scientific discoveries into future breakthroughs, jointly moving businesses, people, and the world forward.

## I Love Lund
- Type: VC Fund
- Location: Lund, Skane Lan, Sweden
- Relevant deals: 2
- Stages: Seed, Pre-Seed
- Focus: Analytics, Biotechnology, Market Research

I Love Lund is a venture capital firm.The firm seeks opportunities to invest in pre-seed rounds

## Andreas Ehn
- Type: Angel
- Location: San Francisco, California, United States
- Relevant deals: 2
- Stages: Seed, Angel, Pre-Seed
- Focus: Software, Internet, Financial Services

Andreas is working on a service that will connect people, time and places on the web. He also works as an independent consultant helping other startups with product strategy, technical infrastructure, scalability and recruiting as well as financial companies (venture capital and private equity) with technical due diligence and in other advisorroles.He was CTO at Spotify from the launch of the company in August 2006 until November 2009. Before that he worked at Stardoll as an engineer and project manager.

## Segulah Medical Acceleration
- Type: VC Fund
- Location: Stockholm, Stockholms Lan, Sweden
- Relevant deals: 2
- Stages: Series A, Series D, Series B
- Focus: Health Care, Medical Device, Biotechnology

Segulah Medical Acceleration is a Scandinavia-based investment company focusing on innovative medical technology companies in Europe.

## Länsförsäkringar
- Type: VC Fund
- Location: Stockholm, Stockholms Lan, Sweden
- Relevant deals: 2
- Stages: Seed, Pre-Seed
- Focus: Real Estate, Biotechnology, Manufacturing

Länsförsäkringar is a Swedish group of public insurance companies.

## SEB Venture Capital
- Type: VC Fund
- Location: Stockholm, Stockholms Lan, Sweden
- Relevant deals: 2
- Stages: Series A, Series B
- Focus: Software, Information Technology, FinTech

SEB Venture Capital is a Fintech investor that helps entrepreneurs and innovators launch and grow profitable businesses. They primarily serve as a strategic corporate venture focused on Fintech investments, with the option of partnering with SEB. They are also on the hunt for game-changing inventive solutions to new technologies that will make thefinancial industry smarter, safer, and more environmentally responsible, as well as more user-friendly. They also function as an evergreen fund, giving them the flexibility and staying strength to focus on long-term wealth development depending on what is best for the firm and its shareholders.

## Boehringer Ingelheim Venture Fund
- Type: VC Fund
- Location: Ingelheim Am Rhein, Rheinland-Pfalz, Germany
- Relevant deals: 2
- Stages: Series A, Series B, Seed
- Focus: Biotechnology, Health Care, Therapeutics

Discover Boehringer Ingelheim Venture Fund. We invest in groundbreaking science to transform care. Explore our mission and join us in advancing medicine

## Flerie Invest
- Type: VC Fund
- Relevant deals: 2
- Stages: Series A, Series B
- Focus: Health Care, Biotechnology, Medical

Flerie is an active long-term life science investor, focusing on biotech and pharmaceutical investments globally.

## LU Holding
- Type: VC Fund
- Relevant deals: 2
- Stages: Pre-Seed
- Focus: Biotechnology

LU Holding is a Lund University’s investment company.

## EIR Ventures
- Type: VC Fund
- Location: Stockholm, Stockholms Lan, Sweden
- Relevant deals: 2
- Stages: Series A, Seed
- Focus: Biotechnology, Health Care, Therapeutics

EIR Ventures is a new Life Science Venture Group in the Nordics.

## Hadean Ventures
- Type: VC Fund
- Location: Oslo, Oslo, Norway
- Relevant deals: 2
- Stages: Series A, Series B
- Focus: Biotechnology, Health Care, Medical

Hadean Ventures is a life science fund manager that invests in life science companies across europe with a particular focus on the nordic region.
The funds are backed by leading private and institutional investors.
Hadean Ventures has offices in oslo and stockholm and collaborates with world-class academic institutions and start-up hubs across theregion

## LIU Invest
- Type: VC Fund
- Location: Linköping, Ostergotlands Lan, Sweden
- Relevant deals: 2
- Stages: Seed, Pre-Seed
- Focus: Biotechnology, Information Technology, AgTech

LIU invests in companies that are based on projects and ideas from Linköping University. LIU Invest is focused on investments in early phases. Investments are typically 250 000, but can be doubled by an additional investment.

## Faro Capital
- Type: VC Fund
- Location: Buenos Aires, Distrito Federal, Argentina
- Relevant deals: 2
- Stages: Series A, Seed
- Focus: Biotechnology, Gaming, Medical

FARO is an Argentina company over 10 years of experience in the development and operation of integrated projects in the agribusiness sector. All projects FARO own position it as a reference and leader both locally and internationally.Among his various projects, FARO operates the largest tree planting pecan nut Latin America, with projection tobecome the largest southern hemisphere and one of the largest in the world. This project is structured under different vehicles, including Alto Pecan stands, the first real estate development of nautical fields planted with pecan nut Latin America, located in Villa Paranacito, Entre Ríos . Another project is AgroConsortium, productive trust for the production and marketing of cereals and oilseeds in leased farms located in different productive areas in Argentina and potentially in the region. Finally, thanks to the expertise acquired in agribusiness, FARO developed his own business model for productive land conversion. Its aim is to position rural properties whose productive potential is not reflected in the price and complement the cycle with the economic use of land in intensive production, short and medium term.Since 2006, the Investor Group is a strategic partner OMBU FARO for all investment portfolios development ventures related to agribusiness, that focus on supply both local and international markets.

## Life Science Invest
- Type: VC Fund
- Location: Bromma, Stockholms Lan, Sweden
- Relevant deals: 2
- Stages: Seed
- Focus: Biopharma, Biotechnology, Pharmaceutical

LSI Academy - New education 2026, read more here

## ARCH Venture Partners
- Type: VC Fund
- Location: Chicago, Illinois, United States
- Relevant deals: 2
- Stages: Series A, Series B, Series C
- Focus: Biotechnology, Health Care, Therapeutics

ARCH Venture Partners provides seed / early stage venture capital for technology firms in information technology, life sciences, and physical sciences

## Forbion Capital Partners
- Type: VC Fund
- Location: Naarden, Noord-Holland, The Netherlands
- Relevant deals: 1
- Stages: Series B, Series A, Series C
- Focus: Biotechnology, Health Care, Medical

Impacting the future of medicine.

## Per Båtelson
- Type: Angel
- Location: Lidingö, Stockholms Lan, Sweden
- Relevant deals: 1
- Stages: Seed, Angel
- Focus: Medical, Health Care, Medical Device

Per Båtelson

## Ysios Capital
- Type: VC Fund
- Location: San Sebastian, Pais Vasco, Spain
- Relevant deals: 1
- Stages: Series A, Series B, Series C
- Focus: Biotechnology, Health Care, Medical

Leading #lifesciences #venturecapital firm financing highly #innovative #biotechnology companies #worlwide.

## Irrus Investments
- Type: VC Fund
- Location: Limerick, Limerick, Ireland
- Relevant deals: 1
- Stages: Seed, Series A
- Focus: Health Care, Medical Device, Biotechnology

Irrus Investments is the leading Irish business angel network with international connections. Fueling Irish innovation in medical devices, software, hardware, digital healthcare and life sciences.

## Glass Wall Syndicate
- Type: VC Fund
- Relevant deals: 1
- Stages: Seed, Pre-Seed, Series C
- Focus: Biotechnology, Health Care, Food and Beverage

Glass Wall Syndicate invests in companies and products that will make a difference in the lives of animals, people, and the planet. It helps grow companies in this space by providing them with capital, resources, mentorship, and other forms of support.The firm is consists of a group of venture capitalists, foundations, trusts, non-profits, andindividual investors who share a similar investment thesis and want to accelerate mainstream adoption of products and services that will make a difference in the lives of animals, people and that are better for the planet.

## Additio Investment Group
- Type: VC Fund
- Location: Barcelona, Catalonia, Spain
- Relevant deals: 1
- Stages: Series A
- Focus: Health Care, Biotechnology, Medical

Value creation for Healthcare & Life Sciences Ventures through capital, expertise, international network.

## Mikael Lonn
- Type: Angel
- Relevant deals: 1
- Stages: Series A
- Focus: Medical, Life Science, Biotechnology

Mikael Lonn is an Angel Investor.

## Ferd
- Type: VC Fund
- Location: Lysaker, Akershus, Norway
- Relevant deals: 1
- Stages: Private Equity, Post-IPO Equity
- Focus: Energy, Software, Manufacturing

Ferd er et familieeid investeringsselskap som er eid av femte og sjette generasjon Andresen.

## Bonnier Ventures
- Type: VC Fund
- Location: Stockholm, Stockholms Lan, Sweden
- Relevant deals: 1
- Stages: Seed, Series A
- Focus: Health Care, Digital Media, Software

Bonnier Capital is the investment division of the Bonnier Group. Since 2016, we invest in promising companies in structurally growing industries and have become a reliant investment partner to companies and funds of various sizes.

## Pär Gellerfors
- Type: VC Fund
- Location: Stockholm, Stockholms Lan, Sweden
- Relevant deals: 1
- Focus: Biotechnology, Medical Device

Pär Gellerfors

## 3B Ventures
- Type: VC Fund
- Location: Kuala Lumpur, Kuala Lumpur, Malaysia
- Relevant deals: 1
- Stages: Series A
- Focus: Medical, Biopharma

We're a traditional non-VC making data driven decisions from the heart.We fund innovation through supporting entrepreneurs that have a passion to create a market disrupting enterprises whilst making a noticeable difference in one, if not multiple of the Sustainable Development Goals set by the UN.Using AI through a dedicated data drivenprocess, we're identifying opportunities and selecting our startups and entrepreneurs based on thousands of data points from a network of partners across the globe.

## Teknoinvest
- Type: VC Fund
- Location: Oslo, Oslo, Norway
- Relevant deals: 1
- Stages: Series B, Series A
- Focus: Health Care, Biotechnology, Medical

Teknoinvest is a premier Scandinavian venture capital company. They invest in areas of emerging technologies within the ITC and Life Sciences sectors. Their main geographical scope is Scandinavia and the USA. Teknoinvest was established as the first venture capital investment company. Teknoinvest is one of the most successful VCÂ´s in Scandinaviaaccording to track record of value created for their investors.

## Josefin Landgård
- Type: Angel
- Location: Stockholm, Stockholms Lan, Sweden
- Relevant deals: 1
- Stages: Seed, Angel, Pre-Seed
- Focus: Health Care, Medical, Women's

Josefin Landgård is the Founder and CEO of Mantle. Previously she served as the Co-Founder and COO at KRY back in March 2014 to September 2018.

## SmiLe Inject Capital
- Type: VC Fund
- Location: Lund, Skane Lan, Sweden
- Relevant deals: 1
- Stages: Seed
- Focus: Medical, Genetics, Analytics

SmiLe Inject Capital is an angel investment company to focus exclusively on early-stage life science companies.

## Annexstruktur
- Type: VC Fund
- Location: Stockholm, Stockholms Lan, Sweden
- Relevant deals: 1
- Stages: Series A
- Focus: Medical, Life Science, Biotechnology

Annexstruktur is a venture capital firm that provides investments to companies.

## Klimatet Invest
- Type: VC Fund
- Location: Gothenburg, Vastra Gotaland, Sweden
- Relevant deals: 1
- Stages: Seed, Series A
- Focus: Energy, Battery, GreenTech

Klimatet Invest is to create long-term value growth by investing relatively early in idea companies with good growth potential in cleantech and at the same time contributing to a more sustainable society.

## Onsight Ventures
- Type: VC Fund
- Location: Innsbruck, Tirol, Austria
- Relevant deals: 1
- Stages: Seed, Series A
- Focus: Manufacturing, Semiconductor, Biotechnology

Pan-european early-stage deep-tech VC

## Investinor
- Type: VC Fund
- Location: Trondheim, Sor-Trondelag, Norway
- Relevant deals: 1
- Stages: Series A, Seed
- Focus: Software, Biotechnology, Manufacturing

Investinor invests in Norwegian based, high potential companies that are internationally oriented and in the phases ranging from early growth to expansion. The company has BNOK 4.2 ($500 m) under management and focus on companies within the internet, software, semiconductors, energy, cleantech, marine and life sciences sectors.

## LifeArc Ventures
- Type: VC Fund
- Location: London, England, United Kingdom
- Relevant deals: 1
- Stages: Series A, Seed
- Focus: Health Care, Fitness, Wellness

LifeArc Ventures a self-funding medical research charity that invests in Seed and Series-A stage Biotech and Healthtech companies.
